Literature DB >> 165882

Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.

F F Becker.   

Abstract

These experiments examined the effects of a single, subcarcinogenic dose of dimethylnitrosamine or N-hydroxyfluorenylacetamide when administered after a subcarcinogenic dietary regimen of N-2-fluorenylacetamide. Control rats that received either carcinogen diet alone or a single dose of carcinogen demonstrated neither hepatic nodules nor hepatocellular carcinomas. Those animals that received dimethylnitrosamine subsequent to carcinogen diet demonstrated many persistent hepatic nodules and 100% hepato-cellular carcinomas. These data support the concept that the nodules produced by subcarcinogenic ingestion of N-2-fluorenylacetamide are not composed simply of normal hepatocytes undergoing compensatory regeneration but consist of cells that have been altered by the carcinogen. One manifestation of this alteration is an increased susceptibility to further carcinogenic evolution.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165882

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Presidential address. Recent concepts of initiation and promotion in carcinogenesis.

Authors:  F F Becker
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

2.  Accumulation of O6-methylguanine in non-target-tissue deoxyribonucleic acid during chronic administration of dimethylnitrosamine.

Authors:  G P Margison; J M Margison; R Montesano
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

3.  Alternative hypotheses for the role of promotion in chemical carcinogenesis.

Authors:  V R Potter
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

4.  Effect of chronic N,N-diethylnitrosamine on the excision of O6-ethylguanine from rat liver DNA.

Authors:  G P Margison; N J Curtin; K Snell; A W Craig
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.